What to know about retatrutide
Retatrutide is the latest experimental weight-loss drug with promising clinical trial results, but it's not yet approved by the FDA. Dr. Céline Gounder has the latest.
Watch CBS News
Retatrutide is the latest experimental weight-loss drug with promising clinical trial results, but it's not yet approved by the FDA. Dr. Céline Gounder has the latest.
California food manufacturer said it is investigating after a consumer posted a video showing a rodent in a jar of the company's peperoncinis.
Recent outbreaks of foodborne illness and high-profile recalls have made food safety a concern of voters.
The FDA has warned a major compounding pharmacy that it violated federal law by making copies of blockbuster weight-loss drugs in "inordinate amounts."
U.S. officials have confirmed cases of a parasitic illness tied to lettuce in three more states: Georgia, Tennessee and Texas.
Patients taking the first-of-a-kind pill, called daraxonrasib, lived for a median of 13.2 months compared with 6.7 months for chemotherapy recipients, studies showed.
It feels like there's been a new food recall every week this summer, but former FDA Commissioner Scott Gottlieb says the number of recalls has been on par with other years. CBS News medical correspondent Dr. Céline Gounder joins "The Takeout" with more.
The USS Washington arrived in the Middle East from Asia on Thursday and relieved the USS Lincoln after a nine-month deployment. The move comes as the Trump administration says it will unveil the "toughest sanctions" on Iran. CBS News' Margaret Brennan and Elliot Ackerman have more.
President Trump announced he's nominating Dr. Heidi Overton, a deputy assistant to the president for domestic policy, to be the next head of the FDA.
The FDA has long fallen short of legally required inspection targets, and foreign inspections fell further last year amid agency layoffs.
CBS News has learned that the Mexican lettuce farm connected to the outbreak of a nasty intestinal illness hasn't been inspected by American regulators in more than seven years. Food safety advocates blame budget and personnel cuts for a 29% drop in inspection rates of foreign farms over the past two years.
The restaurant chain said it pulled the peppers and replaced them with product from another grower amid a food-poisoning probe.
Drugmaker Eli Lilly says it is expanding access to its experimental weight loss drug, retatrutide, which has not been approved yet by the FDA. The company says obese patients taking the drug in clinical trials lost between 73 and 85 pounds over two years. Dr. Rachel Pessah Pollack discusses what we know about its safety, who is eligible for the medication and more.
Two people have died of cyclosporiasis in Michigan, officials said Monday, as the state battles the worst outbreak of the disease in the country. Carter Evans has the details.
The recall affects white-shell and cage-free eggs sold under multiple grocery brands in six states. No illnesses have been reported.
Amid the outbreak of cyclospora, a CBS News poll finds 40% of Americans say they are buying or eating less produce. Nearly half of those polled say they have little or no confidence in the FDA to deal with the outbreak. Carter Evans reports.
Food safety experts say cuts to the public health system hobbled the response — and that the next outbreak could be much worse.
Former FDA commissioner Scott Gottlieb told "Face the Nation with Margaret Brennan" that while the current administration has done a good job isolating and identifying the cyclospora pathogen, the spread isn't "under control yet" and that federal officials need to do more to communicate with the American public. Gottlieb also discussed skyrocketing measles cases and whether that trend is likely to continue.
Nearly as many Americans are following news about the cyclospora parasite as they are the conflict with Iran.
The FDA panel reviewed seven peptides to decide if they should be added to a list of substances that can be safely produced by compounding pharmacies.
The Food and Drug Administration advisory panel is holding a second day of meetings on whether to loosen restrictions on certain unapproved peptide drugs. The panel voted Thursday to broaden access to four peptides. KFF Health News' Amy Maxmen has more.
Federal health officials said they've identified a new outbreak of the cyclospora parasite, but the source hasn't been specified.
U.S. health officials are investigating a new outbreak of the parasite cyclospora that's linked to an unspecified product. Meanwhile, Taco Bell is reporting a major drop in foot traffic as concerns about fresh produce continue. Carter Evans has the latest update and Heather Haddon, a reporter for the Wall Street Journal, joins "The Daily Report" to discuss.
Julie Swann, head of the department of industrial and systems engineering at North Carolina State University, joins "The Daily Report" to discuss the tracking and tracing underway as the U.S.' cyclosporiasis outbreak surpasses 4,000 cases.
Health policy experts say higher import duties could increase costs and strain supplies while offering no guarantee manufacturers will shift production to the U.S.